email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1096 - 1110
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Silenseed Raises $7.8 Million for China RNAi Joint Venture
$5.00
Available
CANbridge to Acquire Gene Therapy for Rare Diseases from Scriptr
$5.00
Available
Kintor Approved to Start Phase I Trial of Dual-Targeting Antibody
$5.00
Available
Shanghai I-Mab to Open San Diego R&D Lab
$5.00
Available
Antengene and LegoChem to Create ADCs Using Antengene's Antibodies
$5.00
Available
ShouTi Closes $100 Million Round for Structure-Based Drug Discovery
$5.00
Available
Chase Raises $20 Million from Hong Kong Investor for Novel Neuro Drugs
$5.00
Available
Zai Lab Says Novel Antibacterial Effective Against a Drug Resistant Pathogen
$5.00
Available
Microtech Medical Stages $233 Million Hong Kong IPO for Diabetes Devices
$5.00
Available
United BioPharma Starts Taiwan-China Trial of Herpes Treatment
$5.00
Available
Hansoh Signs $1.3 Billion siRNA Deal; Its Second siRNA Deal in a Week
$5.00
Available
Innovent Says PD-1 Meets Survival Endpoint in Phase III NSCLC Trial
$5.00
Available
Abbisko Raises $226 Million in Hong Kong IPO for Cancer Therapies
$5.00
Available
GV20 Oncotherapy Closes Series B for Genomics/AI-based mAb Portfolio
$5.00
Available
BeiGene and Bristol-Myers in Fight over China Abraxane Distribution Deal
$5.00
Available